vimarsana.com

Latest Breaking News On - Analyst recommendations for petco health - Page 1 : vimarsana.com

Petco Health and Wellness (NASDAQ:WOOF) Receives Outperform Rating from Wedbush

Wedbush reissued their outperform rating on shares of Petco Health and Wellness (NASDAQ:WOOF – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. They currently have a $4.00 price objective on the stock. Several other research firms also recently commented on WOOF. Citigroup reduced their price objective on Petco Health […]

Petco Health and Wellness (NASDAQ:WOOF) Given New $3 00 Price Target at Royal Bank of Canada

Petco Health and Wellness (NASDAQ:WOOF – Free Report) had its price target increased by Royal Bank of Canada from $2.70 to $3.00 in a research note released on Friday, Benzinga reports. They currently have an outperform rating on the stock. Several other equities research analysts have also commented on WOOF. Evercore ISI reduced their price […]

Wedbush Increases Petco Health and Wellness (NASDAQ:WOOF) Price Target to $4 00

Petco Health and Wellness (NASDAQ:WOOF – Free Report) had its target price raised by Wedbush from $3.00 to $4.00 in a research note published on Thursday morning, Benzinga reports. The firm currently has an outperform rating on the stock. A number of other equities analysts have also recently weighed in on the company. Needham & […]

Petco Health and Wellness (NASDAQ:WOOF) Rating Reiterated by Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of Petco Health and Wellness (NASDAQ:WOOF – Free Report) in a research note released on Thursday, Benzinga reports. They currently have a $5.00 price target on the stock. Several other brokerages have also issued reports on WOOF. Bank of America reaffirmed an underperform rating and […]

Petco Health and Wellness (NASDAQ:WOOF) Receives Buy Rating from Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of Petco Health and Wellness (NASDAQ:WOOF – Free Report) in a research report sent to investors on Thursday morning, Benzinga reports. They currently have a $5.00 target price on the stock. Other equities analysts have also recently issued research reports about the company. UBS Group […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.